People with metabolic dysfunction-associated steatotic liver disease, or MASLD, may face greater liver-scarring risk when they concentrate alcohol consumption into heavy drinking episodes, according to research reported by Keck Medicine of USC.
The April 2026 report described an analysis of National Health and Nutrition Examination Survey data from more than 8,000 adults collected between 2017 and 2023.
Researchers defined episodic heavy drinking as at least four drinks in a day for women or five for men, at least once a month. Among people with MASLD, that pattern was associated with roughly three times the likelihood of advanced fibrosis compared with spreading the same total intake over time.
The comparison concerns a specific population and an association in survey data. It does not mean that one heavy drinking occasion triples every person’s future risk, or that spreading alcohol across days makes drinking safe.
Principal investigator Brian Lee advised avoiding episodic heavy drinking even when usual consumption is moderate. People with fatty liver disease should discuss alcohol use and their individual liver-health risks with a healthcare professional.
